Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers

Prostate Cancer and Prostatic Diseases

Volumn 12, Issue 3, 2009, Pages 247-252

  Tanaka, M ^a   Fujimoto, K ^a   Chihara, Y ^a   Torimoto, K ^a   Yoneda, T ^a   Tanaka, N ^a   Hirayama, A ^a   Miyanaga, N ^b   Akaza, H ^b   Hirao, Y ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; DAIDZEIN; EQUOL; GENISTEIN; ISOFLA A; ISOFLAVONE DERIVATIVE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG URINE LEVEL; ESTRADIOL BLOOD LEVEL; EVENING DOSAGE; HUMAN; HUMAN EXPERIMENT; MALE; MORNING DOSAGE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SUPPLEMENTATION; TESTOSTERONE BLOOD LEVEL;

ADULT; CHOLESTEROL; DIETARY SUPPLEMENTS; DIHYDROTESTOSTERONE; GENISTEIN; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SEX HORMONE-BINDING GLOBULIN;

EID: 70249102071     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2009.10     Document Type: Article

References (30)

1. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hämäläinen E, Hasegawa T et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991; 54: 1093-1100.
2. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 1999; 129: 1628-1635.
3. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996; 87: 897-904.
4. Wei H, Cai Q, Rahn RO. Inhibition of UV light-and Fenton reaction -induced oxidative DNA damage by the soybean isoflavone genistein. Carcinogenesis 1996; 17: 73-77.
5. Shao ZM, Alpaugh ML, Fontana JA, Barsky SH. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by p21WAF1/CIP1 induction, G2/ M arrest and apoptosis. J Cell Biochem 1998; 69: 44-54.
6. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 1993; 90: 2690-2694.
7. Price KR, Fenwick GR. Naturally occurring oestrogens in foods- a review. Food Addit Contam 1985; 2: 73-106.
8. Petersen DN, Tkalcevic GT, Koza-Taylor PH, Turi TG, Brown TA. Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues. Endocrinology 1998; 139: 1082-1092.
9. Déchaud H, Ravard C, Claustrat F, de la Perrière AB, Pugeat M. Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids 1999; 64: 328-334.
10. Martin ME, Haourigui M, Pelissero C, Benassayag C, Nunez EA. Interactions between phytoestrogens and human sex steroid binding protein. Life Sci 1996; 58: 429-436.
11. Hedlund TE, Johannes WU, Miller GJ. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 2003; 54: 68-78.
12. Lund TD, Munson DJ, Haldy ME, Setchell KD, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 2004; 70: 1188-1195.
13. Fujimoto K, Tanaka M, Hirao Y, Nagata Y, Mori M, Miyanaga N et al. Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men. Prostate Cancer Prostatic Dis 2008; 11: 252-257.
14. Urban D, Irwin W, Kirk M, Markiewicz MA, Myers R, Smith M et al. The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J Urol 2001; 165 294-300.
15. Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, Doerge D et al Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 2003; 47: 111-117.
16. Kumar NB, Cantor A, Allen K, Riccardi D, Besterman-Dahan K, Seigne J et al. The specific role of isoflavones in reducing prostate cancer risk. Prostate 2004; 59: 141-147.
17. Maskarinec G, Morimoto Y, Hebshi S, Sharma S, Franke AA, Stanczyk FZ. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men. Eur J Clin Nutr 2006; 60: 1423-1429.
18. Kumar NB, Krischer JP, Allen K, Riccardi D, Besterman-Dahan K, Salup R et al. Safety of purified isoflavones in men with clinically localized prostate cancer. Nutr Cancer 2007; 59: 169-175.
19. Coward L, Kirk M, Albin N. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 1996; 247: 121-142.
20. Carter HB, Coffey DS. The prostate: An increasing medical problem. Prostate 1990; 16: 39-48.
21. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85 60-67.
22. Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982; 29: 611-616.
23. Wynder EL, Rose DP, Cohen LA. Nutrition and prostate cancer: A proposal for dietary intervention. Nutr Cancer 1994; 22: 1-10.
24. Oishi K, Okada K, Yoshida O, Yamabe H, Ohno Y, Hayes RB et al. A case-control study of prostatic cancer with reference to dietary habits. Prostate 1988; 12: 179-190.
25. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991; 83: 541-546.
26. Peterson G, Barnes S. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 1993; 22: 335-345.
27. Pollard M, Wolter W, Sun L. Prevention of induced prostate-related cancer by soy protein isolate/isoflavone-supplemented diet in Lobund-Wistar rats. In Vivo 2000; 14: 389-392.
28. Perabo FG, Von Löw EC, Ellinger J, von Rücker A, Müller SC, Bastian PJ. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis 2008; 11: 6-12.
29. Nagata Y, Sonoda T, Mori M, Miyanaga N, Okumura K, Goto K et al. Dietary isoflavones may protect against prostate cancer in Japanese men. J Nutr 2007; 137: 1974-1979.
30. Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T et al Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 2004; 34: 86-89.